Top

Published in:

01-09-2014 | Original Article

4-Phenylbutyric acid attenuates endoplasmic reticulum stress-mediated pancreatic β-cell apoptosis in rats with streptozotocin-induced diabetes

Authors: Min Zhu, Mei Guo, Li Fei, Xiao-qin Pan, Qian-qi Liu

Published in: Endocrine | Issue 1/2014

Abstract

Endoplasmic reticulum stress (ERS) plays an important role in diabetes mellitus (DM), but the association between DM and ERS is unknown. We have previously shown that streptozotocin (STZ)-induced diabetes in rats is characterized by increased levels of ERS markers. Here, we tested whether the chemical chaperone 4-phenylbutyric acid (4-PBA) ameliorated ERS-associated apoptosis in pancreatic β-cells in rats with STZ-induced diabetes. Male Sprague–Dawley rats were divided into 3 groups: control group, DM group, and DM model plus 4-PBA treatment group (4-PBA group). DM model rats were induced by injection of STZ (60 mg/kg) intraperitoneally, and 4-PBA was administered daily by gavage at a dose of 500 mg/kg body weight for 20 days. β-cell apoptosis was higher in the DM group than in the control group. Moreover, the expression of caspase-3, Bax, and the ERS indicators Bip and CHOP was markedly elevated in the pancreas of rats in the DM group, whereas the expression of Bcl-2 was lower in these rats (P < 0.05). Blood glucose concentration in diabetic rats gradually decreased with 4-PBA treatment but remained higher at the end of the experiment compared to the concentration in control rats. Consistent with this, 4-PBA raised the fasting insulin level in diabetic rats; it also suppressed the expression of caspase-3, Bax, and ERS indicators but enhanced the expression of Bcl-2. In conclusion, 4-PBA protects pancreatic β-cells from apoptosis in STZ-induced diabetes by attenuating the severity of ERS.

J. Su, L. Zhou, X. Kong et al., Endoplasmic reticulum is at the crossroads of autophagy, inflammation, and apoptosis signaling pathways and participates in the pathogenesis of diabetes mellitus. J. Diabetes Res. 2013, 193461 (2013). doi:10.1155/2013/193461 PubMedCentralPubMed

R.G. Mirmira, Saturated free fatty acids: islet β cell “stressERs”. Endocrine 42, 1–2 (2012). doi:10.1007/s12020-012-9713-0 PubMedCentralPubMedCrossRef

M.S. Hwang, W.K. Baek, Glucosamine induces autophagic cell death through the stimulation of ER stress in human glioma cancer cells. Biochem. Biophys. Res. Commun. 399, 111–116 (2010). doi:10.1016/j.bbrc.2010.07.050 PubMedCrossRef

S.E. Choi, Y.J. Lee, H.J. Jang et al., A chemical chaperone 4-PBA ameliorates palmitate-induced inhibition of glucose-stimulated insulin secretion (GSIS). Arch. Biochem. Biophys. 475, 109–114 (2008). doi:10.1016/j.abb.2008.04.015 PubMedCrossRef

T. Szkudelski, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50, 537–546 (2001)PubMed

S. Roy, S.K. Metya, S. Sannigrahi, F. Ahmed et al., Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β cell. Endocrine 44, 369–379 (2013). doi:10.1007/s12020-012-9868-8 PubMedCrossRef

N. Lin, H. Chen, H. Zhang et al., Mitochondrial reactive oxygen species (ROS) inhibition ameliorates palmitate-induced INS-1 beta cell death. Endocrine 42, 107–117 (2012). doi:10.1007/s12020-012-9633-z PubMedCrossRef

I. Marhfour, X.M. Lopez, D. Lefkaditis et al., Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 55, 2417–2420 (2012). doi:10.1007/s00125-012-2604-3 PubMedCrossRef

K.L. Lipson, S.G. Fonseca, F. Urano, Endoplasmic reticulum stress-induced apoptosis and autoimmunity in diabetes. Curr. Mol. Med. 6, 71–77 (2006)PubMedCrossRef

10.

A.K. Cardozo, F. Ortis, J. Storling et al., Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ATPase 2b and deplete endoplasmic reticulum Ca2 +, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 54, 452–461 (2005)PubMedCrossRef

11.

W. Sun, Y. Bi, H. Liang et al., Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats. Endocrine 39, 235–241 (2011). doi:10.1007/s12020-010-9429-y PubMedCrossRef

12.

N. Sato, F. Urano, L.J. Yoon et al., Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression. Nat. Cell Biol. 25, 863–870 (2000)

13.

N.L. Vanderford, Defining the regulation of IL-1β and CHOP-mediated β-cell apoptosis. Islets 2, 334–336 (2010)PubMedCrossRef

14.

S.A. Tersey, Y. Nishiki, A.T. Templin et al., Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the non-obese diabetic mouse model. Diabetes 61, 818–827 (2012). doi:10.2337/db11-1293 PubMedCentralPubMedCrossRef

15.

M. Vilatoba, C. Eckstein, G. Bilbao et al., Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery 138, 342–351 (2005)PubMedCrossRef

16.

N. Sawada, J. Yao, N. Hiramatsu et al., Involvement of hypoxia-triggered endoplasmic reticulum stress in outlet obstruction-induced apoptosis in the urinary bladder. Lab. Invest. 88, 553–563 (2008). doi:10.1038/labinvest.2008.21 PubMedCrossRef

17.

Z.F. Luo, B. Feng, J. Mu et al., Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation. Toxicol. Appl. Pharmacol. 246, 49–57 (2010). doi:10.1016/j.taap.2010.04.005 PubMedCrossRef

18.

W. Qi, J. Mu, Z.F. Luo et al., Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response. Metabolism 60, 594–603 (2011). doi:10.1016/j.metabol.2010.07.021 PubMedCrossRef

19.

U. Ozcan, E. Yilmaz, L. Ozcan et al., Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137–1140 (2006)PubMedCrossRef

Title: 4-Phenylbutyric acid attenuates endoplasmic reticulum stress-mediated pancreatic β-cell apoptosis in rats with streptozotocin-induced diabetes
Authors: Min Zhu
Mei Guo
Li Fei
Xiao-qin Pan
Qian-qi Liu
Publication date: 01-09-2014
Publisher: Springer US
Published in: Endocrine / Issue 1/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-013-0132-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

The essential use of FNA-calcitonin for detecting medullary thyroid cancer

Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database

PTH-C1: a rat continuous cell line expressing the parathyroid phenotype

Current prevalence of goiter determined by ultrasonography and associated risk factors in a formerly iodine-deficient area of Turkey

McArdle’s disease in the seventh decade: challenges in diagnosis and management

DNA demethylation enhances myoblasts hypertrophy during the late phase of myogenesis activating the IGF-I pathway

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials